Paratek Pharmaceuticals, Inc. reports

Company location: Boston, MA
Fiscal year end: 31 December

Paratek Pharmaceuticals, Inc. has filed 1,336 SEC EDGAR filings since 23 Jul 2002

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 101-125 of 958 matching filings.

Per page

25

Current page

5

10-K File 001-36066

10-K

Filing date: 16 Mar 2023
Reporting date: 31 Dec 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36066

8-K

Filing date: 14 Mar 2023
Reporting date: 14 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 23 Feb 2023
Reporting date: 21 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 23 Feb 2023
Reporting date: 21 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-81821

SC 13G/A filing

Filing date: 15 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-81821

SC 13G/A filing

Filing date: 13 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 09 Feb 2023
Reporting date: 08 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 09 Feb 2023
Reporting date: 08 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 09 Feb 2023
Reporting date: 08 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 09 Feb 2023
Reporting date: 08 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 09 Feb 2023
Reporting date: 08 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 09 Feb 2023
Reporting date: 08 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 09 Feb 2023
Reporting date: 08 Feb 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-81821

SCHEDULE 13G/A

Filing date: 20 Jan 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 22 Dec 2022
Reporting date: 20 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 22 Dec 2022
Reporting date: 20 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 22 Dec 2022
Reporting date: 20 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 22 Dec 2022
Reporting date: 20 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 22 Dec 2022
Reporting date: 20 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 14 Dec 2022
Reporting date: 12 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 14 Dec 2022
Reporting date: 12 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 14 Dec 2022
Reporting date: 12 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 14 Dec 2022
Reporting date: 12 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 14 Dec 2022
Reporting date: 12 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-36066

10-Q

Filing date: 03 Nov 2022
Reporting date: 30 Sep 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .